{"title":"审判中的掠夺性期刊:FTC诉OMICS对学术出版的指控、回应和教训","authors":"Stewart Manley","doi":"10.3138/JSP.50.3.02","DOIUrl":null,"url":null,"abstract":"Abstract:On 25 August 2016, the US Federal Trade Commission (FTC) sued OMICS Group Inc., iMedPub LLC, Conference Series LLC, and Srinubabu Gedela, all affiliated with open access mega-publisher OMICS International, for deception in their solicitation of journal articles and advertising of conferences. The ongoing lawsuit seeks to stop OMICS's deceptive practices and disgorge US $50.5 million in ill-gotten gains. OMICS has in turn claimed over $2.1 billion for harm caused by the lawsuit to its business and employees. This article describes the main arguments, counter-arguments, and court decisions in the 5920 pages of pleadings, exhibits, and orders that have been filed through 14 October 2018. The article then evaluates the case to formulate key take-aways for publishers, editors, academics, and universities. Depending on its ultimate outcome, the case against OMICS may be a turning point in the practices of questionable open access online publishers, making this interim case assessment pertinent to all concerned about the future of academic publishing.","PeriodicalId":44613,"journal":{"name":"Journal of Scholarly Publishing","volume":"11 1","pages":"183 - 200"},"PeriodicalIF":1.2000,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"24","resultStr":"{\"title\":\"Predatory Journals on Trial: Allegations, Responses, and Lessons for Scholarly Publishing from FTC v. OMICS\",\"authors\":\"Stewart Manley\",\"doi\":\"10.3138/JSP.50.3.02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract:On 25 August 2016, the US Federal Trade Commission (FTC) sued OMICS Group Inc., iMedPub LLC, Conference Series LLC, and Srinubabu Gedela, all affiliated with open access mega-publisher OMICS International, for deception in their solicitation of journal articles and advertising of conferences. The ongoing lawsuit seeks to stop OMICS's deceptive practices and disgorge US $50.5 million in ill-gotten gains. OMICS has in turn claimed over $2.1 billion for harm caused by the lawsuit to its business and employees. This article describes the main arguments, counter-arguments, and court decisions in the 5920 pages of pleadings, exhibits, and orders that have been filed through 14 October 2018. The article then evaluates the case to formulate key take-aways for publishers, editors, academics, and universities. Depending on its ultimate outcome, the case against OMICS may be a turning point in the practices of questionable open access online publishers, making this interim case assessment pertinent to all concerned about the future of academic publishing.\",\"PeriodicalId\":44613,\"journal\":{\"name\":\"Journal of Scholarly Publishing\",\"volume\":\"11 1\",\"pages\":\"183 - 200\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2019-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"24\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Scholarly Publishing\",\"FirstCategoryId\":\"91\",\"ListUrlMain\":\"https://doi.org/10.3138/JSP.50.3.02\",\"RegionNum\":4,\"RegionCategory\":\"管理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"0\",\"JCRName\":\"HUMANITIES, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Scholarly Publishing","FirstCategoryId":"91","ListUrlMain":"https://doi.org/10.3138/JSP.50.3.02","RegionNum":4,"RegionCategory":"管理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"HUMANITIES, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 24
摘要
摘要:2016年8月25日,美国联邦贸易委员会(FTC)起诉OMICS Group Inc.、iMedPub LLC、Conference Series LLC和Srinubabu Gedela,这四家公司均隶属于开放获取大型出版商OMICS International,指控其在期刊文章征发和会议广告中存在欺诈行为。正在进行的诉讼旨在制止OMICS的欺诈行为,并收回5050万美元的非法所得。OMICS则要求赔偿21亿美元以上的损失,以弥补诉讼对公司业务和员工造成的损失。本文描述了截至2018年10月14日提交的5920页诉状、证据和命令中的主要论点、反论点和法院判决。然后,本文对案例进行了评估,为出版商、编辑、学者和大学制定了关键的结论。根据其最终结果,反对OMICS的案例可能是有问题的开放获取在线出版商实践的转折点,使这个临时案例评估与所有关心学术出版未来的人息息相关。
Predatory Journals on Trial: Allegations, Responses, and Lessons for Scholarly Publishing from FTC v. OMICS
Abstract:On 25 August 2016, the US Federal Trade Commission (FTC) sued OMICS Group Inc., iMedPub LLC, Conference Series LLC, and Srinubabu Gedela, all affiliated with open access mega-publisher OMICS International, for deception in their solicitation of journal articles and advertising of conferences. The ongoing lawsuit seeks to stop OMICS's deceptive practices and disgorge US $50.5 million in ill-gotten gains. OMICS has in turn claimed over $2.1 billion for harm caused by the lawsuit to its business and employees. This article describes the main arguments, counter-arguments, and court decisions in the 5920 pages of pleadings, exhibits, and orders that have been filed through 14 October 2018. The article then evaluates the case to formulate key take-aways for publishers, editors, academics, and universities. Depending on its ultimate outcome, the case against OMICS may be a turning point in the practices of questionable open access online publishers, making this interim case assessment pertinent to all concerned about the future of academic publishing.
期刊介绍:
For more than 40 years, the Journal of Scholarly Publishing has been the authoritative voice of academic publishing. The journal combines philosophical analysis with practical advice and aspires to explain, argue, discuss, and question the large collection of new topics that continually arise in the publishing field. JSP has also examined the future of scholarly publishing, scholarship on the web, digitization, copyright, editorial policies, computer applications, marketing, and pricing models. It is the indispensable resource for academics and publishers that addresses the new challenges resulting from changes in technology and funding and from innovations in production and publishing.